Capricor Therapeutics CAPR
NASDAQ CAPR
$10.37 -0.85 (-7.58%)
As of: Nov 12, 2026 · 2:11 PM EST

Capricor Therapeutics (CAPR) Sales of Property, Plant and Equipment (2010 - 2026)

Updated

Analysis

Capricor Therapeutics (CAPR) Sales of Property, Plant and Equipment (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Capricor Therapeutics 515.69 Mn -516.56 Mn - 23,590.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23,590.00
Sep 30, 2011 -2,500.00
Mar 31, 2011 2,500.00
Mar 31, 2010 2,500.00
API Access

Capricor Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=CAPR&period=max&api_key=YOUR_API_KEY